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Macrophages responding to viral infections may contribute to autoimmune demyelinating diseases (ADD). Macrophages from ADD-
susceptible SJL/J mice responding to Theiler's Virus (TMEV) infection, the TLR7 agonist loxoribine, or the TLR4 agonist-LPS expressed less IL-
12 p35 but more IL-12/23 p40 and IFN-β than macrophages from ADD-resistant B10.S mice. While expression of IRF-1 and -7 was similar
between B10.S and SJL/J TMEV-infected macrophages, SJL/J but not B10.S macrophages exhibited constitutively active IRF-3. In contrast to
overexpressed IRF-1, IRF-5, and IRF-7, which stimulated p35 promoter reporter activity, overexpressed IRF-3 repressed p35 promoter activity in
response to TMEV infection, loxoribine, IFN-γ/LPS, but not IFN-γ alone. IRF-3 lessened but did not eliminate IRF-1-stimulated p35 promoter
activity. Repression by IRF-3 required bp −172 to −122 of the p35 promoter. The data suggest that pre-activated IRF-3 is a major factor in the
differences in IL-12 production between B10.S and SJL/J macrophages responding to TMEV.
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In addition to T cells, macrophages are a consistent part of
the inflammatory lesions associated with multiple sclerosis
(MS), an autoimmune demyelinating disease (ADD) (Woo-
droofe et al., 1986). It is hypothesized that T cells and
macrophages within the lesions mutually trigger each other's
contribution to MS pathology. There is also evidence that
genetic (Walsh et al., 2003) and environmental factors (Sayetta,
1986) play roles in development of MS. It is likely that certain
viral infections induce the immune responses associated with
MS (Haahr et al., 2004; Sundstrom et al., 2004). Research with
Theiler's murine encephalomyelitis virus (TMEV), which
causes MS-like symptoms in SJL/J mice (H-2s) but not B10.S
mice (H-2s) (Aubagnac et al., 2002; Monteyne et al., 1999;
Vigneau et al., 2003), has revealed how viruses could cause MS.
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(Olson et al., 2001). In this model, TMEV infects macrophages,
neurons, oligodendrocytes, and microglial cells in the brain of
both strains of mice (Lipton et al., 2005; Oleszak et al., 2004).
Both strains of mice develop effector T cells specific for TMEV
epitopes. However, after 2 weeks, TMEV persists in macro-
phages that infiltrate the white matter of the CNS in SJL/J but
not B10.S mice. This persistent infection of SJL/J macrophages
by TMEV induces expression of specific cytokines, which
contribute to the development of the autoreactive T cells that
cause ADD but which fail to clear the virus. We have found that
macrophage expression of IL-12 is lower, while IFN-β
expression is higher during the innate anti-TMEV immune
responses of SJL/J compared with B10.S macrophages (Petro,
2005). We hypothesize that the IL-12low/IFN-βhigh phenotype
of SJL/J macrophages permits viral persistence and is a
significant factor in the development of TMEV-induced ADD.
Interferon-beta (IFN-β) and IL-12 are macrophage cytokines
that together provide substantial innate anti-viral immunity
(Cousens et al., 1999). IFN-β stimulates the cytotoxic capacity
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IL-12 stimulates NK cell proliferation, induces expression of
IFN-γ from NK cells (Nguyen et al., 2002), and induces nitric
oxide from macrophages (Pahan et al., 2001). Therefore,
imbalances in production of IFN-β and IL-12 during the innate
anti-viral immune response could contribute to viral persistence.
However, IL-12 also plays a role in the nature of the adaptive
CD4 T cell response (Hsieh et al., 1993). IL-12 is a
heterodimeric cytokine composed of p35 and p40 subunits,
each of which could combine with alternate subunits (Wolf et
al., 1991). While p35 alternately combines with EBI-3
(Devergne et al., 1996, 1997), p40 also combines with a p19
subunit to form IL-23 (Oppmann et al., 2000). Mice deficient in
p40 or p19 lose the capacity to develop experimental allergic
encephalomyelitis (EAE), an alternate animal model of MS.
However, mice deficient in p35 exhibit more intense EAE (Cua
et al., 2003; Gran et al., 2002, 2004). Therefore, IL-23 but not
IL-12 plays a detrimental role in development of EAE. We have
reported that the deficiency in IL-12 production by SJL/J
macrophages infected with TMEV is associated with less p35
expression compared with B10.S macrophages but significantly
greater IFN-β and p40 expression (Petro, 2005). However, it is
unclear what causes this deficiency in p35 expression by SJL/J
macrophages.
IRFs are activated during viral infection of macrophages
through Toll-like receptor (TLR) signaling systems (Malmgaard,
2004; Ozato et al., 2002). A picornavirus such as TMEV is
expected to stimulate macrophages through TLR3, a dsRNA
receptor, and TLR7, an ssRNA receptor. Viral infection of
macrophages induces expression of IRF-1, 5, and 7, which then
enter the nucleus to function as transcription factors (Malmgaard,
2004). In contrast, IRF-3 is constitutively expressed in the
cytoplasm, hyperphosphorylated by TLR3-activated TBK1/IKKε
following viral infection, and then localizes to the nucleus to
function as a transcription factor (Lin et al., 1999). Therefore, the
roles of IRF-1, 3, 5, and 7 in IL-12 p35/p40 expression by B10.S
and SJL/J macrophages during the innate immune response to
TMEV were evaluated. The results indicate that IRF-3 is
constitutively active in SJL/J macrophages compared with B10.
S macrophages. IRF-3 activation dampens expression of IL-12
p35 but not p40 or IFN-β.
Results
Differences in IL-12 p35, p40, and IFN-β expression of
TMEV-infected SJL/J and B10.S macrophages
Expression of TMEV RNA is greater in TMEV-infected
macrophages from female SJL/J mice compared with B10.S
mice (Petro, 2005) despite higher IL-12 p40 and IFN-β
expression by the former. However, production of IL-12 by
SJL/J macrophages following infection with TMEV was less
than that of B10.S macrophages (Petro, 2005). Differences in
macrophage viability following infection could account for this
divergence. In order to determine macrophage viability after
TMEV infection, B10.S and SJL/J macrophages were infected
with various TMEV MOI and 24-h MTT assays wereperformed. The results show that B10.S macrophages exhibited
an MOI-related 30 to 40% decline in viability compared with
uninfected B10.S macrophages at 24 h following infection (Fig.
1). In contrast, SJL/J macrophages infected with TMEV did not
experience any decline in macrophage viability compared with
uninfected SJL/J macrophages. Therefore, the greater IFN-β
expression by TMEV-infected SJL/J macrophages may prevent
macrophage death but does not prevent TMEV persistence
(Petro, 2005).
In order to determine the temporal relationship of the
cytokine responses to TMEV infection, SJL/J and B10.S
macrophages were infected with TMEV (MOI 0.25) for 3, 8,
24, and 48 h before assessment of p35, p40, and IFN-β
expression with quantitative RT-PCR. The expression of p35 by
B10.S macrophages was significantly greater than that of SJL/J
macrophages from 3 to 48 h post-infection with TMEV, as
determine by ANOVA (F = 25.29, P = 0.0001) (Fig. 2A).
Expression of the IL-12 p40 subunit was apparent from 3 h to
24 h post-infection with TMEV in both B10.S and SJL/J
macrophages (Fig. 2B). Similar to our previous results, SJL/J
macrophages responding to TMEV had significantly higher p40
expression compared with B10.S macrophages from 3 h to 24 h
post-infection (F = 5.91, 0.027). As previously reported, SJL/J
macrophages exhibited significantly higher constitutive expres-
sion of IFN-β compared with B10.S macrophages. By 8 h post-
infection, both B10.S and SJL/J macrophages exhibited an
increase in IFN-β expression (Fig. 2C). However, the level of
IFN-β expression by SJL/J macrophages was significantly
greater than that of B10.S macrophages 8 h post-infection
(F = 15.85, P = 0.001).
Differences in IL-12 p35, p40, and IFN-β expression in
TLR4- and TLR7-stimulated SJL/J and B10.S macrophages
It is expected that the response of macrophages to TMEV
depends upon signaling through TLR3 (Alexopoulou et al.,
2001) and TLR7 (Diebold et al., 2004) pathways which respond
to dsRNA and ssRNA, respectively. In addition, certain viruses
appear to stimulate macrophages through the TLR4 pathway
(Ehl et al., 2004). Previously, we have seen that the p35
response of SJL/J macrophages to the TLR7 agonist loxoribine
is lower than the p35 response of B10.S macrophages (Petro,
2005). However, the comparative responses of these macro-
phages to TLR3 and TLR4 agonists are not known. Therefore,
expression of p35, p40, and IFN-β by B10.S and SJL/J
macrophages stimulated with poly IC, LPS, and loxoribine was
evaluated by qRT-PCR. Similar to our previous findings, B10.S
macrophages exhibited significantly higher expression of p35
(Fig. 3A) but lower expression of p40 (Fig. 3C) compared with
SJL/J macrophages responding to the TLR7 agonists loxor-
ibine. However, loxoribine did not induce IFN-β expression in
macrophages of either strain (Fig. 3D). In contrast, poly IC
failed to stimulate p35 (Fig. 3A) expression but did induce
similar levels of p40 and IFN-β expression (Figs. 3C and D) in
both B10.S and SJL/J macrophages. Expression of p35 but not
p40 in response to LPS was higher in B10.S macrophages
compared with SJL/J macrophages (Fig. 3B). Therefore, IL-12
Fig. 2. Temporal pattern of p35, p40, and IFN-β expression in response to
TMEV infection. Real-time PCR of p35 (A), p40 (B), and IFN-β (C) mRNA in
SJL/J and B10.S macrophages before and 24 h after infection with TMEV.
1 × 106 macrophages were uninfected (nil) or infected with 1 × 106 PFU of
TMEV for 3, 8, 24, and 48 h. Relative levels of p35, p40, and IFN-β mRNA
were evaluated by real-time PCR. Overall data were evaluated by ANOVA for
main effects due to murine strain. Individual means of 3–5 samples each of a
representative experiment were evaluated with Student's t test. Comparisons of
means in which P values ≤0.05 are bracketed.
Fig. 1. Viability of B10.S and SJL/J macrophages 24 h after infection with
TMEV. 1 × 105 macrophages in 96-well plates were uninfected (nil) or infected
with 0.1, 0.5, or 1.0 MOI of TMEV for 24 h. Ten microliters of MTT at 5 mg/ml
was added for 4 h. Following addition of 100 μl of isopropanol/0.04N HCl, ODs
at 570 nm were used to estimate viability of the macrophages. Data are
means ± SE of 5 replicates.
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and TLR7 stimulation is higher while IFN-β expression in
response to TMEV and TLR3 stimulation is lower in B10.S
compared to SJL/J macrophages.
SJL/J macrophages exhibit constitutively active IRF-3 but
similar expression of IRF-1 and IRF-7
IRFs plays an important role in p35 expression (Kollet et al.,
2001; Kollet and Petro, 2006), and stimulation through TLR3, 4,
and 7 induces expression of IRF-1 (Siren et al., 2005) and IRF-7
(Gautier et al., 2005). Therefore, we measured IRF-1 and IRF-7
expression in B10.S and SJL/J macrophages responding to
TMEV by qRT-PCR. B10.S and SJL/J macrophages expressed
similar levels of IRF-1 (Fig. 4A) and IRF-7 (Fig. 4B) as early as
3 h extending for at least 24 h after infection with TMEV.
Therefore, the differences in p35 expression between SJL/J and
B10.S macrophages are not due to expression of either IRF-1 or
IRF-7.
IRF-3 is also involved in p35 expression (Goriely et al.,
2006), and stimulation through TLR3 and 4 but not TLR7
activates IRF-3 (Gautier et al., 2005). However, in contrast to
IRF-1 and IRF-7, IRF-3 is constitutively expressed, is activated
by hyperphosphorylation, localizes to the nucleus, facilitates
expression of IFN-β, exits the nucleus, and then is degraded (Lin
et al., 1999). Therefore, total and nuclear IRF-3 in B10.S and
SJL/J macrophages before and after TMEV infection was
examined by Western immunoblot. The results show that the
IRF-3 expressed by SJL/J macrophages has a distinctly lower
molecular weight compared with IRF-3 expressed by B10.S
macrophages (Fig. 5A). In addition, IRF-3 was constitutively
present in the nucleus of SJL/J but not B10.S macrophages (Fig.
5A). Following TMEVor poly IC stimulation, IRF-3 localized to
the nucleus of B10.S macrophages. Nuclear IRF-3 of B10.S
macrophages was of a slightly higher molecular weight com-
pared with nuclear IRF-3 of SJL/J macrophages. IRF-3 in B10.Sand SJL/J macrophages was also evaluated by fluorescent
microscopy using DAPI to identify nuclei and antibody to
identify IRF-3. IRF-3 was detectable in the nucleus of some
SJL/J macrophages before infection with TMEV (Fig. 5B). The
overall intensity of cytoplasmic IRF-3 staining was greater in
uninfected SJL/J macrophages compared with B10.S macro-
phages. In addition, there appeared to be numerous uninfected
SJL/J macrophages with more intense perinuclear IRF-3, which
was not found in uninfected B10.S macrophages. The intensity
of IRF-3 staining decreased in both B10.S and SJL/J macro-
phages by 1 h after TMEV infection (Fig. 5B). However, IRF-3
Fig. 3. Temporal pattern of p35 (A, B), p40 (B, C), and IFN-β (D) expression in response to TLR3, TLR4, and TLR7 stimulation. Real-time PCR of (A) p35 mRNA
expressed in response to 50 μg/ml poly IC or 200 μM loxoribine (Lox), (B) p35 and p40 mRNA expressed in response to 1 μg/ml LPS, (C) p40 or (D) IFN-β mRNA
expressed in response to poly IC or Lox. Expression of mRNAwas from 1 × 106 SJL/J and B10.S macrophages 24 h after stimulation. Data are means of 3–5 samples
each of a representative experiment evaluated by the Student's t test. Comparisons in which P values ≤0.05 are bracketed.
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B10.S macrophages. By 3 h after TMEV infection, the intensity
of IRF-3 staining increased in B10.S macrophages more than
SJL/J macrophages (Fig. 5B). In addition, IRF-3 localized to the
nucleus in many of the B10.S macrophages but only some of the
SJL/J macrophages. Thus, constitutively active IRF-3 may
contribute to differences in the innate anti-viral immune
response of SJL/J compared with B10.S macrophages.
IRF-1, IRF-5, and IRF-7 enhance while IRF-3 represses p35
promoter activity
Therefore, IRF-1, -7, and -3 may play important roles in p35
and p40 expression following TMEV infection. Recently, IRF-5
was shown to play a role in cytokine expression by virus-
infectedmacrophages (Barnes et al., 2001; Takaoka et al., 2005).
Previously, we have shown that RAW264.7 cells can be infected
with and respond to TMEV (Petro, 2005). In order to assess the
contributions of IRF-1, 3, 5, or 7 in p35 or p40 promoter activity
during TMEV infection, expression vectors for each IRF were
transfected into RAW264.7 cells along with p35 or p40
luciferase promoter reporter vectors which were then infected
with TMEVor left uninfected. Enforced expression of IRF-1, 5,
or 7 significantly elevated p35 promoter activity even without
TMEV infection. TMEV infection alone induced p35 promoter
activity and augmented p35 promoter activity of RAW264.7
cells overexpressing IRF-1, 5, or 7 (Fig. 6A). In contrast,overexpression of IRF-3 alone did not induce p35 promoter
activity and suppressed TMEV-induced p35 promoter activity.
Therefore, activated IRF-3 appears to suppress p35 promoter
activity. Overexpression of IRF-3, 5, or 7 but not IRF-1
stimulated p40 promoter activity of uninfected RAW264.7 cells.
TMEV infection alone stimulated p40 promoter activity, while
overexpressed IRF-7 augmented p40 promoter activity in
response to TMEV infection (Fig. 6B). The impact of IRF-3
overexpression on p35 promoter activity in TMEV-infected, as
well as LPS (TLR4)- and loxoribine (TLR7)-stimulated
RAW264.7 cell was examined. The results show that IRF-3
overexpression suppressed TMEV-induced (Fig. 7A), as well as
loxoribine (Fig. 7A)- and LPS (Fig. 7B)-induced p35 promoter
activity. In contrast, previous studies have shown that IFN-γ is a
potent inducer of IRF-1, IRF-1 is needed for p35 expression, and
IRF-1 overexpression augments responses to LPS, a TLR4
agonist. Interestingly, LPS induces IRF-1 (Barber et al., 1995),
activates IRF-3 (Fitzgerald et al., 2003), and yet induces p35
expression (Gautier et al., 2005). Therefore, the impact of IRF-1
overexpression with and without IRF-3 overexpression on p35
promoter activity in TMEV-infected, as well as LPS (TLR4)-
and loxoribine (TLR7)-stimulated RAW264.7 cell was exam-
ined. As expected, IRF-1 overexpression augmented p35
promoter activity in response to TMEV (Fig. 7A), LPS (Fig.
7B), or loxoribine (Fig. 7A). Overexpression of IRF-3 with IRF-
1 reduced but did not eliminate p35 promoter activity in TMEV
(Fig. 7A)-, LPS (Fig. 7B)-, or loxoribine (Fig. 7A)-stimulated
Fig. 4. Temporal pattern of IRF-1 and IRF-7 expression in response to TMEV
infection. Real-time PCR of (A) IRF-1 or (B) IRF-7 mRNA of 1 × 106 SJL/J and
B10.S macrophages responding to for 3, 8, 24, and 48 h. Data are means of 3–5
samples each of a representative experiment.
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overcome the control of p35 expression by IRF-3.
IRF-3 requires bp −172 to −122 of the p35 promoter to repress
gene expression
Recently, we reported that IRF-1 binds to an IRF element
within bp −131 to −126 while NF-κB binds to bp −110 to −101
of the p35 promoter (Kollet and Petro, 2006). To determine if
this also corresponds to the site in which IRF-3 can confer
repression of p35 promoter activity, RAW264.7 cells were
transfected with an IRF-3 expression vector plus promoter
reporter vectors containing the full-length p35 promoter or
mutants of the p35 promoter with 5′ deletions as we have
previously reported (Kollet et al., 2001). Deletions of the p35
promoter from bp −809 to −172 did not affect the ability of
overexpressed IRF-3 to inhibit p35 promoter activity in response
to TMEV infection. However, deletion of bp from −172 to −122
of the p35 promoter eliminated the ability of IRF-3 to inhibit p35
promoter activity in response to TMEV infection. Reporter
constructs with bp −122 to +1 of the p35 promoter were
responsive to TMEV infection despite IRF-3 overexpression.
Therefore, IRF-3 may bind at or in close proximity to the IRF
element at bp−131 to−126 of the p35 promoter to suppress gene
expression (Fig. 8).Discussion
IL-23 p19/p40 but not IL-12 p35/p40 plays a detrimental role
in the EAE model of MS (Becher et al., 2003; Cua et al., 2003;
Gran et al., 2002). Our previous report showed that controlling
TMEV infection of SJL/J and B10.S macrophages is positively
correlated with production of IL-12, specifically its p35 subunit
(Petro, 2005). In order to determine the mechanism for this
disparity in expression of IL-12, we evaluated IRF transcription
factors in B10.S and SJL/J macrophages which are induced or
activated by TMEV infection and which are known to play a
role in macrophage cytokine production. The results of the
present investigation clearly show that there are major
differences in IRF-3 but not IRF-1 and IRF-7 activity between
SJL/J and B10.S macrophages. Surprisingly, IRF-3 is consti-
tutively present in nuclei of SJL/J macrophages but not in B10.S
macrophages. This difference in activity of IRF-3 is significant
because we show here that overexpression of IRF-3 represses
expression of the p35 subunit of IL-12 but not expression of the
p40 subunit following TMEV infection.
SJL/J macrophages express a slightly smaller isoform of
IRF-3. It is possible that this isoform of IRF-3 is its alternate
isoform, IRF-3a (Karpova et al., 2001). IRF-3 has an N-terminal
DNA-binding domain and a C-terminal signal response domain
with several serine/threonine phosphorylation sites (Schafer et
al., 1998; Wathelet et al., 1998). IRF-3a has an alternate N-
terminal 20 aa and a slightly smaller molecular weight but
retains the signal response domain phosphorylation sites
(Karpova et al., 2001). Because IRF-3a represses activity of
some but not all IRF-3-responsive promoters, it is possible that
the smaller IRF-3 isoform in SJL/J macrophages might repress
p35 expression. However, IRF-3a represses IFN-β expression
and SJL/J macrophages express higher levels of IFN-β before
and after TMEV infection compared with B10.S macrophages.
Therefore, it is unlikely that the smaller IRF-3 isoform of SJL/J
macrophages is IRF-3a.
The cause of the constitutively active IRF-3 in SJL/J
macrophages is unclear but could conceivably be due to activity
of TLR pathways. TLR3 activates IRF-3 and NF-κB while
TLR7 activates NF-κB but not IRF-3 (Takeda and Akira, 2005;
Janssens and Beyaert, 2003; Diebold et al., 2004). However, the
TLR3 ligand, poly IC, stimulated similar levels of IFN-β
expression from both B10.S and SJL/J macrophages despite the
fact that TMEV stimulated higher levels of IFN-β from SJL/J
compared with B10.S macrophages. Therefore, TLR3 pathway
activity may not explain the constitutively active IRF-3 of SJL/J
macrophages. RNA-dependent protein kinase (PKR), a cyto-
plasmic viral RNA sensor, is also a potent IRF-3 activator
(Balachandran et al., 2000; Servant et al., 2002). It is possible
that the differences in IRF-3 activation are related to PKR.
Intriguingly, several genes termed TMEVp1, located on
chromosome 17, and TMEVp2 and TMEVp3, located near
the IFN-γ locus of the murine chromosome 10, are significant
factors in the differences between SJL/J and B10.S mice
resistance to TMEV (Vigneau et al., 2003). However, the gene
for TLR3 and IRF-3 is located on chromosomes 8 and 7,
respectively, whereas the PKR gene is located on chromosome
Fig. 5. Nuclear and cytoplasmic IRF-3 in SJL/J or B10.S macrophages. (A) Immunoblots of total and nuclear IRF-3 of SJL/J or B10S macrophages responding to
1 × 106 PFU of TMEVor 50 μg/ml poly IC after 3 h or (B) IRF-3 immunofluorescence and DAPI nuclear staining of SJL/J and B10.S macrophages responding to
1 × 106 TMEV PFU for 0, 1 or 3 h. Arrows indicate nuclei with IRF-3.
427A. Dahlberg et al. / Virology 353 (2006) 422–43217. It remains to be seen if the TMEVp1 polymorphisms are
related to PKR activity.
Surprisingly, the higher expression of IFN-β by SJL/J
macrophages did not confer greater resistance to TMEV
infection. IFN-β and TMEV RNA expression by TMEV-
infected B10.S macrophages is lower than that of SJL/J
macrophages. This seems paradoxical. However, a previous
study showed that long-term IFN-β treatment of SJL/J mice with
TMEV-ADD actually exacerbated demyelination (Njenga et al.,
2000). These results suggest that IFN-β alone cannot eliminate
persistent infection of macrophages by TMEV. However, B10.S
macrophages do not have a generally lower IFN-β response
because their expression of IFN-β in response to poly IC wassimilar to that of SJL/J macrophages. It is more likely that the L-
protein of TMEV interferes with IFN-β expression in B10.S
macrophages (van Pesch et al., 2001; Delhaye et al., 2004).
However, the depressed IL-12 response of SJL/J mice may cause
greater susceptibility to other viruses such as murine adenovirus
(Welton et al., 2005), Hantaan virus (Wichmann et al., 2002),
and a murine endogenous retrovirus (De Rossi et al., 1981). In
contrast, the elevated IFN-β response of SJL/J mice may confer
better resistance to certain viruses such as rabies virus (Lodmell,
1983) and the murine hepatitis virus (Knobler et al., 1981). The
results herein suggest that balanced production of both IL-12 and
IFN-β bymacrophages is required to prevent persistent infection
with viruses like TMEV.
Fig. 6. The responsiveness of the p35 (A) and p40 (B) promoters to
overexpressed IRF-1, IRF-3, IRF-5, and IRF-7. The activities of the p35 or
p40 promoter reporter vectors transfected into RAW264.7 cells with pTarget
IRF-1, pUNO-IRF-3, pUNO-IRF-5, or pUNO-IRF-7 plus pRL-SV40 respond-
ing to infection with 1 × 106 PFU of TMEV. Promoter activity was measured as
firefly-luciferase-dependent luminescence of stimulated cells normalized to
Renilla-luciferase-dependent luminescence at 24 h after infection. Data are
mean ± standard error of 5 replicates from a representative experiment. Data are
means of 5 samples each of a representative experiment evaluated by Student's t
test. Comparisons in which P values ≤0.05 were considered significantly
different are denoted with an *.
Fig. 7. The responsiveness of the p35 promoter to overexpressed IRF-1 with or
without overexpressed IRF-3. The activity of the p35 promoter in RAW264.7
cells co-transfected with pTarget IRF-1 with or without pBRST-IRF-3 plus pRL-
SV40 responding to (A) TMEV or 200 μM Loxoribine (Lox) or (B) 1 μg/ml
LPS, 10 ng IFN-γ, or LPS/IFN-γ. Promoter activity was measured as firefly-
luciferase-dependent luminescence of stimulated cells normalized to Renilla-
luciferase-dependent luminescence after 24 h of infection or stimulation. Data
are mean ± standard error of 5 replicates from a representative experiment. Data
are means of 5 samples each of a representative experiment evaluated by
Student's t test. Comparisons in which P values ≤0.05 were considered
significantly different are bracketed.
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1 for maximal p35 expression (Kollet et al., 2001; Kollet and
Petro, 2006). The present investigation shows that IRF-5 and
IRF-7, in addition to IRF-1, play a significant positive role in
expression of p35. In contrast, IRF-3 plays a significant
negative role in p35 gene expression and likely uses the IRF
element at bp −131 to −126. Therefore, IRF-3 and IRF-1
conceivably compete for the same IRF element in the p35
promoter during the TMEV infection. However, when both
IRF-1 and IRF-3 were overexpressed simultaneously before
infection with TMEVor stimulation with LPS, LPS/IFN-γ, and
loxoribine, significant p35 promoter activity was maintained.
This suggests that IRF-1 effectively competes with IRF-3 but
cannot completely overcome IRF-3 repression to maintain p35
promoter activity.
In summary, the results of this report clearly show that SJL/J
macrophages have heightened IRF-3 activity before and afterinfection with TMEV, which appears to dampen p35 expression
but heighten IFN-β expression. This heightened IRF-3 activity
results in a higher ratio of IFN-β to IL-12 expression from
TMEV-infected macrophages and may contribute to the
persistent infection of SJL/J macrophages by TMEV.
Materials and methods
Experimental animals, cell line, virus, and reagents
Female B10.S and SJL/J mice were obtained from Jackson
Laboratories (Bar Harbor, Maine). RAW264.7 cells were
originally obtained from the American Type Culture Collection
(Rockville, MD). Loxoribine (Invivogen, San Diego, CA) was
used at 200 μM, and poly IC (Invivogen) was used at 50 μg/ml
from. E. coli LPS O127:B8 (Sigma Chemical Co., St. Louis,
MO) was used at 1 μg/ml. The DA strain of TMEV was
obtained from Dr. Kristen Drescher, Department of Medical
Fig. 8. The IRF-3-dependent inhibition of the p35 expression in response to TMEV infection is dependent upon bp −172 to −122 of the p35 promoter. The activities of
the p35 promoter (bp −809 to +1) with no deletions or mutated promoters with the indicated 5′ deletions in the pGL3 enhancer reporter vector were determined in
transfected RAW264.7 cells co-transfected pUNO-IRF-3 plus pRL-SV40 followed by infection with 1 × 106 PFU of TMEV. Promoter activity was measured as firefly-
luciferase-dependent luminescence of stimulated cells normalized to Renilla-luciferase-dependent luminescence in 24-h cell extracts divided by values obtained from
unstimulated cells normalized to Renilla luciferase. Data are mean ± standard error; * indicates that the mean is significantly different from the response to TMEV
without exogenous IRF, P < 0.05.
429A. Dahlberg et al. / Virology 353 (2006) 422–432Microbiology and Immunology, Creighton University, Omaha,
Nebraska. TMEVwas grown in BHK-21 cells. The titer of stock
cultures of TMEV was 2.5 × 106 PFU/ml, and macrophages
cultures were infected with 2.5 × 105 PFU of TMEV.
Expression plasmids
Full-length murine IRF-1 cDNA in pTarget (Promega) has
been described previously (Kollet et al., 2001). Full-length
murine IRF-3 cDNA in pBPSRT1 was generously provided by
the laboratory of Dr. David E. Levy (Marie et al., 1998), and
IRF-3 cDNA in pUNOwas obtained from Invivogen. IRF-5 and
IRF-7 inserted into pUNO expression vector were obtained
from Invivogen. Plasmids were purified with endotoxin-free
plasmid maxi-kit of Qiagen (Valencia, CA).
Preparation, treatment, and infection of macrophages
Macrophages were obtained from the peritoneal cavity 3 days
after intraperitoneal injection of 2 ml thioglycollate broth into
mice. Peritoneal macrophages were collected, incubated at
1 × 106 cells/2 ml of DMEM cell culture medium (Invitrogen,
Carlsbad, CA) containing 10% fetal bovine serum (FBS)
(Invitrogen), and 50 μg/ml gentamycin (Invitrogen). After
24 h, non-adherent cells were removed and 1 ml of culture
medium added. The adherent macrophages were greater than
90% Mac-1+ as determined by FACS analysis. Adherent
macrophages were either untreated or treated with loxoribine
(200 μM), poly IC (50 μg/ml), LPS (1 μg/ml) with or without
IFN-γ (10 ng/ml), or infected with 100 μl of the TMEV stock
(2.5 × 105 PFU). After 1, 6, or 24 h, cell extracts were obtained
for IRF-3 Western immunoblots, or after 3, 8, 24, or 48 h, cell
extracts were collected for RT-PCR.Nuclear extract preparation
Nuclear extracts were prepared from 3 × 106 stimulated or
unstimulated peritoneal macrophages using the nuclear extract
kit of Active Motif (Carlsbad, CA) according to manufacturer's
specifications. Cells were harvested after 3 h as previously
published (Kollet et al., 2001). Nuclei were collected after
10 min at 4 °C with rotation in that buffer containing 0.1% NP-
40. Nuclear proteins were recovered by incubation in buffer
containing 20 mM HEPES pH 7.9, 400 mM NaCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 20% glycerol, 1 mM DTT,
1 mM PMSF, and 1% aprotinin for 30 min at 4 °C. The extract
was recovered after centrifugation and diluted in buffer
containing 20 mM HEPES pH 7.9, 50 mM KCl, 0.2 mM
EDTA, 0.2 mM EGTA, 20% glycerol, 1 mM PMSF and 1 mM
DTT. Nuclear extracts were stored at −80 °C.
Quantitative real-time PCR
RNA was extracted using the RNAeasy kit of Qiagen
(Valencia, CA) according to the manufacturer's specifications.
One microgram of RNA in 12.5 μl water was added to 1 μl of
20 μM oligodeoxy-thymidine and heated to 70 °C for 2 min.
The RNA was then incubated with 50 mM Tris–HCl, pH 8.3,
75 mM KCl, 3 mM MgCl2, and 0.5 mM each of dATP, dGTP,
dTTP, and dCTP, 20 U of RNAse inhibitor, and 525 U of
MMLV reverse transcriptase (Invitrogen) at 42 °C for 1.5 h
followed by 94 °C for 5 min. One twenty-fifth of the cDNA
sample was incubated with 0.4 μMof the following primer pairs
(Invitrogen): for p35 sense primer 5′ ACATCACACGGGAC-
CAAACC 3′ and antisense fluorogenic primer 5′ cacaacGG-
CAGCTCCCTCTTGTTG [FAM] G 3′ were designed using the
Light Upon Extension software of Invitrogen. All other primers
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GAC 3′ and antisense 5′ TTCCCTATTTTCCGTGGCTGGG 3′;
β-actin sense 5′ GTG GGCCGCTCTAGGCACCAA 3′ and
antisense 5′ CTCTTTGAT GTCACGCACGATTTC 3′ were
used. For real-time PCR of IFN-β, p40, and β-actin cDNA, the
Platinum-SYBER Green I-UDG-quantitative PCR SuperMix
(Invitrogen) was used. For real-time PCR of p35 cDNA, the
Platinum Quantitative PCR SuperMix-UDG was used. One
microliter of cDNA was mixed with 1.5 units of Platinum Taq
DNA polymerase, 110 mM Tris–HCl, 50 mM KCl, 3 mM
MgCl2, 200 μM dGTP, 200 μM dATP, 200 μM dCTP, 400 μM
dUTP, and 1 U of uracil–DNA glycosylase (UDG) containing
0.5 μM 5-carboxy-X-rhodamine, succinimidyl ester reference
dye. Quantitative SYBER Green based PCR reactions were run
on an ABI Prism 7000 thermal-cycler program using a 2-step
cycling of 50 °C for 2 min, 95 °C for 2 min followed by 40 cycles
of 95 °C, for 15 s/60 °C for 30 s for reactions. Quantitative p35
PCR reactions used a 3-step cycling of 50 °C for 2 min, 95 °C
for 2 min, followed by 45 cycles of 95 °C, for 15 s/55 °C for
30 s/72 °C for 30 s. Relative levels of cDNA were compared
with that of β-actin cDNA utilizing the formula: 2ΔΔCt where
Ct = cycle threshold.
PAGE and Western blot analysis of IRF-3
Cell extracts of unstimulated and stimulated macrophages
were made using lysis buffer (Cell Signaling, Beverly, MA)
containing 20 mM Tris–HCl, 150 mM NaCl, 1 mM Na2EDTA,
1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
beta-glycerophosphate, 1 mM Na3VO4, 1 μg/ml leupeptin, and
1 mM PMSF. The cell extracts were added to a sample buffer
containing 63 mM Tris–HCl, 10% glycerol, 2% SDS, 2.5% 2-
ME, and 0.0025% bromophenol blue. Protein concentrations in
cell and nuclear extracts were determined using the BioRad
(Hercules, CA) DC protein assay kit. Twenty microliters of each
sample containing 10 μg of protein was applied to a 10% SDS,
Tris–glycine–polyacrylamide gel in a running buffer of 25 mM
Tris base, 192 mM glycine, and 0.1% SDS. Current was applied
at 125 V for 90 min. Transfer at 25 V for 1 h was made to a
polyvinylidene difluoride membrane in a 12 mM Tris base,
96 mM glycine, and 20% methanol transfer buffer. The
membrane was treated with blocking buffer for 1 h at room
temperature followed by incubation in a 1:1000 dilution of
rabbit IgG anti-IRF-3 (Zymed/Invitrogen) and then 1:1000
dilution of IRDye 800CW Goat Anti-Rabbit IgG (Rockland
Immunochemicals, Inc., Gilbertsville, PA). The membrane was
washed three times and then interrogated with a LICOR
Odyssey Infrared Imaging System.
Immunofluorescence
Macrophages fixed in 4% formaldehyde/PBS for 20 min
were permeabilized with methanol and treated with blocking
buffer. Rabbit anti-IRF-3 at 1:100 was added overnight at 4 °C.
After washing, FITC–anti-rabbit IgG at 1:100 was added for
60 min. Cells were then stained with 4′,6-diamidino-2-
phenylindole (DAPI) at 3 μM in buffer containing 100 mMTris, pH 7.4, 150 mMNaCl, 1 mMCaCl2, 0.5 mMMgCl2, 0.1%
Nonidet P-40). After washing, samples were viewed using an
Olympus iX81 Confocal InvertedMicroscope at theMicroscopy
Core Research Facility of the University of Nebraska. Images
were captured and analyzed using FluoView 500 software. All
figures were compiled in Adobe Photoshop 6.0.
IL-12 p35 and p40 promoters and transfections
An 810 bp section of the murine p35 promoter from −809 nt
to +1 nt relative to the ATG start site and an 861 bp fragment of
the murine p40 promoter −890 nt to −29 nt up from the ATG
start site were inserted separately into the pGL3 vectors
(Promega, Madison WI) as has been previously described
(Kollet et al., 2001). 5′ deletions were made in the p35 promoter
to remove potential transcriptional regulatory elements as has
been previously described (Kollet et al., 2001). Plasmids were
isolated from transformed E. coli JM109 utilizing the Qiagen
endotoxin-free plasmid Maxi Kit according to manufacturer's
specifications. To determine the responsiveness of the pGL3
reporter constructs, RAW264.7 cells were seeded at 3 × 105 per
2 ml of culture medium. After 24 h, cells were transfected using
a total of 1 μg p35pGL3 or p40pGL3 reporter constructs plus
1 μg pCIneo empty vector, IRF-1pTarget, IRF-3pBSRT (a kind
gift from Dr. David Levy), IRF-3pUNO, IRF-5pUNO, or IRF-
7pUNO with 10 μg of lipofectamine (Invitrogen), and 0.05 μg
of pRL-SV40 that constitutively expresses Renilla luciferase.
After 24 h, transfected cells were incubated with or without
Loxoribine, poly IC, IFN-γ/LPS, or TMEV. Twenty four hours
after stimulation, transfected RAW264.7 cells were washed
twice with PBS and treated with Passive Lysis Buffer according
to manufacturer's specifications (Promega, Madison, WI). Cell
lysates were frozen, vortexed, centrifuged at 12,000 × g for 15 s,
before collection of supernatant. Twenty microliters of super-
natant was mixed with 100 μl of substrate from the Dual
Luciferase detection kit (Promega). Luminescence was mea-
sured with a Turner Design luminometer. Firefly luminescence
for each culture was normalized to the Renilla luciferase
luminescence in each culture.
Statistical analysis
Data in Fig. 2 were subjected to a two-way analysis of
variance to detect significant main effects due to mouse strain
and time after infection. In addition, all data with numerical
values were analyzed by Student's t test to determine the
significance of differences between the mean values of
experimental samples compared with the mean values of the
control (unstimulated) samples. P values of less than 0.05 were
considered to be significant.
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